OKLO closed Friday at $36.22, down roughly 9% on the day. The trigger was straightforward: on September 11, Oklo entered its second $1 billion at-the-market equity offering in four months, deploying a ten-bank syndicate that includes Goldman Sachs, BofA Securities, Citigroup, J.P. Morgan, and Morgan Stanley as sales agents. The new program replaces a facility dated May 13, 2026, which Oklo terminated effective September 10 after selling 17,971,448 shares for approximately $1 billion in gross proceeds. One program exhausted in four months, a fresh one live the next morning.
America’s Energy Armageddon
The expert Barron’s describes as visionary premieres a global “shockumentary”
Discover how woke progressives played politics with the energy grid as part of a potential plot to “blackout” the U.S. economy in 2026…
See firsthand who’s being set up to prosper and who could be wiped out (FREE to stream!)
What Oklo Actually Is
Oklo develops fission power plants to provide energy at scale, centered on the Aurora Powerhouse, designed to produce up to 75 megawatts of electricity. It is also pursuing nuclear fuel recycling and related fuel-cycle capabilities intended to support its reactors. The business model is compelling on paper: own and operate compact fast-fission reactors, sell power directly to data centers and industrial customers under long-term contracts, and close the fuel cycle with recycled material.
The gap between that vision and current reality is the entire investment debate. With no meaningful revenue today, Oklo is burning cash and has had to raise capital to shore up its balance sheet. Shares outstanding have risen sharply, and Oklo’s cash burn has been substantial as it scales.
The Numbers Behind the Offering
- Q1 2026 cash and equivalents: The company reported roughly $1.6 billion of cash and equivalents as of March 31, 2026, plus roughly $0.9 billion of marketable securities.
- Q1 2026 net loss: $33.1 million for the three months ended March 31, 2026, with operating loss of $51.2 million.
- Accumulated deficit: $273.8 million as of March 31, 2026.
- Prior ATM average price: 17.97 million shares sold at an average of $55.64 under the May program.
- New ATM implied dilution: Should Oklo raise the full $1 billion near $40 per share, it would issue roughly 25 million additional shares, diluting existing shareholders by approximately 11.5%.
- Shares outstanding: 186.02 million.
- Agent commission: Up to 1.5% of gross sales price per share sold.
Why the Stock Keeps Falling
Programs like this tend to pressure a stock because selling more shares dilutes existing shareholders. Investors often price in some of that dilution as soon as a program is announced, even before any shares are actually sold. But there is a second, harder problem. With negligible current revenues and negative operating cash flows, this is a high-risk investment. The first ATM was drawn down at an average of $55.64. The second opens near $40. Each successive raise happens at a lower price, stretching the share count required to fund the same dollar amount of development spending.
Insiders have been active sellers. In June, co-founder and COO Caroline Cochran sold shares in transactions reported at prices in the mid-$60s to low-$70s, and co-founder and CEO Jacob DeWitte also reported sales in that range, per SEC filings. Following Friday’s decline, Oklo shares are trading at less than half their price at the start of 2026.
Trump Put $25M Here. Most Investors Missed It.
A little-known AI infrastructure fund has reportedly attracted Trump’s attention.
Now ordinary investors may have a way to learn about it for around $15.
Regulatory Progress, Genuine but Partial
The bull case rests on execution, and there has been real movement. The NRC has been engaged in pre-application interactions with Oklo for the Aurora Powerhouse, and the company has described progress on key safety and design workstreams. Progress is genuine. Final commercial operating approval remains outstanding.
Only two SMR systems are currently operable worldwide, one in China and one in Russia. The Russian project began construction in 2007 and did not begin operations until 2020. Oklo’s first Aurora power delivery is targeted for 2028. That timeline is ambitious against any historical comparison, and the share count required to get there expands with every new offering.
Bull / Base / Bear
Bull: The Aurora at Idaho National Laboratory reaches first power in 2028 on schedule. NRC licensing milestones arrive ahead of consensus. A major signed power-purchase agreement, possibly tied to the 1.2-gigawatt Meta framework signed in January, rerates the stock before the new ATM is fully drawn. Cash on hand supports operating burn for several years without forced selling at distressed prices.
Base: The ATM is drawn down gradually over 12-18 months at prices in the $35-50 range, adding 20-28 million shares. Regulatory milestones proceed on the current pace. The stock trades in a wide, volatile range tied to AI power-demand headlines and SMR sentiment. No revenue before late 2027 at earliest.
Governments worldwide are investing billions to revive a proven energy source. Supply chains are tightening, demand is rising, and select companies stand to benefit. The Nuclear’s Second Act report explains what’s happening next.
Bear: A further delay in NRC approval pushes first power beyond 2028. Cash burn accelerates as headcount grows. A third ATM opens near or below $30, compounding dilution at the worst possible price. Shares are already down sharply from 2025 highs. Sentiment-driven de-rating removes the valuation floor entirely.
Technical Overlay
OKLO closed Friday at $36.22, near its 52-week low of $36.61. The 52-week high stands at $193.84. There is no meaningful technical support between current levels and the low-$30s. An ATM program structurally suppresses sharp recoveries: any price spike invites incremental selling by the agents.
Bottom Line
The real question is not whether Oklo’s technology works. It is how many shares must be issued before it earns a dollar. Management has signaled continued use of at-the-market equity as a primary funding tool, alongside other potential financing sources. That is honest disclosure and cold comfort for shareholders watching the denominator grow. The 2028 reactor case remains intact, but each new billion-dollar offering demands that the Aurora timeline be exactly right. There is no revenue cushion if it slips.
